|
DESCRIPTION• Modeling hemophilia in degenerated stem cells using the gene scissors (TALEN) • First mutant gene correction using CRISPR / Cas9 in iPS cells of patients • Corrected cells had no nonspecific mutations and we identified the validation through hemophilia mouse model • Identify the possibility of cell therapy through self-transplantation Features & ContactSign in and you'll be able to send enquiries about this item, view full details and save it
|